efavirenz 400 MG / lamivudine 300 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet
RxNorm concept 2001424, clinical drug (scd). Prescribable name: efavirenz 400 MG / lamiVUDine 300 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet.
- RxCUI
- 2001424
- Term type
- Clinical drug (SCD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2001424 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
efavirenz 400 MG / 3TC 300 MG / Tenofovir disoproxil fumarate 300 MG Oral Tablet; efavirenz 400 MG / lamiVUDine 300 MG / tenofovir disoproxil fumarate 300 MG (equivalent to tenofovir disoproxil 245 MG) Oral Tablet; efavirenz 400 MG / lamiVUDine 300 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet; efavirenz 400 MG / lamivudine 300 MG / tenofovir disoproxil fumarate 300 MG (equivalent to tenofovir disoproxil 245 MG) Oral Tablet
Related concepts
- lamivudine 300 MG (SCDC, consists of)
- tenofovir disoproxil fumarate 300 MG (SCDC, consists of)
- efavirenz 400 MG (SCDC, consists of)
- Oral Tablet (DF, has dose form)
- efavirenz 400 MG / lamivudine 300 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet [Symfi] (SBD, has tradename)
Linked data
NDCs
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 2001424 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2001424 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2001424. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.